AptarGroup, Inc. $ATR Stake Boosted by Dempze Nancy E

Dempze Nancy E increased its stake in AptarGroup, Inc. (NYSE:ATR) by 1.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,358 shares of the industrial products company’s stock after purchasing an additional 373 shares during the quarter. AptarGroup makes up 2.2% of Dempze Nancy E’s investment portfolio, making the stock its 19th largest holding. Dempze Nancy E’s holdings in AptarGroup were worth $3,810,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of ATR. Focus Partners Wealth grew its stake in AptarGroup by 94.4% during the 1st quarter. Focus Partners Wealth now owns 65,871 shares of the industrial products company’s stock valued at $9,774,000 after acquiring an additional 31,985 shares in the last quarter. Simplex Trading LLC grew its stake in AptarGroup by 107.4% during the 1st quarter. Simplex Trading LLC now owns 224 shares of the industrial products company’s stock valued at $33,000 after acquiring an additional 116 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in AptarGroup by 8.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 228,066 shares of the industrial products company’s stock valued at $33,840,000 after acquiring an additional 18,315 shares in the last quarter. Royal Bank of Canada grew its stake in AptarGroup by 4.8% during the 1st quarter. Royal Bank of Canada now owns 131,284 shares of the industrial products company’s stock valued at $19,480,000 after acquiring an additional 6,031 shares in the last quarter. Finally, Avantax Advisory Services Inc. grew its stake in AptarGroup by 18.2% during the 1st quarter. Avantax Advisory Services Inc. now owns 2,256 shares of the industrial products company’s stock valued at $335,000 after acquiring an additional 348 shares in the last quarter. Hedge funds and other institutional investors own 88.52% of the company’s stock.

Insider Buying and Selling

In other AptarGroup news, insider Shiela Vinczeller sold 1,167 shares of the company’s stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $137.97, for a total transaction of $161,010.99. Following the completion of the sale, the insider owned 25,134 shares of the company’s stock, valued at $3,467,737.98. This represents a 4.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gael Touya sold 2,500 shares of the company’s stock in a transaction that occurred on Thursday, September 11th. The stock was sold at an average price of $136.12, for a total value of $340,300.00. Following the transaction, the insider owned 31,463 shares of the company’s stock, valued at approximately $4,282,743.56. This trade represents a 7.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.68% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Raymond James Financial reaffirmed an “outperform” rating and set a $172.00 target price (down previously from $182.00) on shares of AptarGroup in a research note on Monday, August 4th. Weiss Ratings cut AptarGroup from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Wednesday. Wells Fargo & Company lowered their target price on AptarGroup from $153.00 to $152.00 and set an “overweight” rating on the stock in a research note on Wednesday, September 10th. Finally, KeyCorp started coverage on AptarGroup in a research note on Wednesday, September 3rd. They set an “overweight” rating and a $220.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, AptarGroup currently has an average rating of “Moderate Buy” and a consensus target price of $182.00.

AptarGroup Trading Up 0.8%

Shares of NYSE ATR opened at $131.57 on Thursday. The stock has a market cap of $8.67 billion, a price-to-earnings ratio of 22.65, a PEG ratio of 2.69 and a beta of 0.55. The business has a 50 day simple moving average of $137.15 and a 200 day simple moving average of $147.10. AptarGroup, Inc. has a 52 week low of $129.81 and a 52 week high of $178.03. The company has a debt-to-equity ratio of 0.20, a quick ratio of 0.83 and a current ratio of 1.21.

AptarGroup (NYSE:ATR) last announced its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.66 EPS for the quarter, beating the consensus estimate of $1.58 by $0.08. The business had revenue of $966.01 million during the quarter, compared to analysts’ expectations of $954.06 million. AptarGroup had a return on equity of 15.39% and a net margin of 10.84%.The firm’s quarterly revenue was up 6.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.41 EPS. AptarGroup has set its Q3 2025 guidance at 1.530-1.610 EPS. On average, research analysts predict that AptarGroup, Inc. will post 5.57 earnings per share for the current fiscal year.

AptarGroup Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 13th. Shareholders of record on Thursday, October 23rd will be given a dividend of $0.48 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This is an increase from AptarGroup’s previous quarterly dividend of $0.45. This represents a $1.92 dividend on an annualized basis and a yield of 1.5%. AptarGroup’s dividend payout ratio (DPR) is currently 33.05%.

AptarGroup Profile

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.